Elizabeth Hackbarth

Elizabeth Hackbarth is a seasoned professional in patient advocacy with extensive experience in the pharmaceutical industry. Currently serving as Director of Patient Advocacy at Alexion Pharmaceuticals, Inc. since May 2021, Elizabeth has previously held similar roles at Regeneron Pharmaceuticals, Inc. and Hackbarth Consulting, LLC. With a strong background at Amgen and Forest Laboratories, Elizabeth built advocacy initiatives targeting cardiovascular health, respiratory conditions, and mental health support, while also developing an education platform for health technology assessments. Elizabeth's career began at the American Heart Association, where relationship management and fundraising for global programs were key responsibilities. Elizabeth holds a Bachelor of Arts in Interdisciplinary Social Science from the University of South Florida.